The pharma giant said amycretin led to weight loss and diabetes reductions in both injection and pill versions.
Orforglipron, a GLP-1 drug taken as a pill, achieved positive results in people with obesity and type 2 diabetes, although it ...
Popular weight loss shots carry significant risk for some patients and doctors often fail to discuss those risks with ...
Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...
People taking weight loss injections are mistakenly eating too little, according to a pharmacist. Jason Murphy, head of ...
The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond ...